The Angiotensin-Converting Enzyme Inhibitor Lisinopril Mitigates Memory and Motor Deficits in a Drosophila Model of Alzheimer’s Disease

The use of angiotensin-converting enzyme inhibitors (ACEis) has been reported to reduce symptoms of cognitive decline in patients with Alzheimer’s disease (AD). Yet, the protective role of ACEis against AD symptoms is still controversial. Here, we aimed at determining whether oral treatment with the...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Jimiece, Smith, Haddon, Smith, C. Aaron, Coward, Lori, Gorman, Gregory, De Luca, Maria, Jumbo-Lucioni, Patricia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830455/
https://www.ncbi.nlm.nih.gov/pubmed/35366264
http://dx.doi.org/10.3390/pathophysiology28020020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830455/
https://www.ncbi.nlm.nih.gov/pubmed/35366264
http://dx.doi.org/10.3390/pathophysiology28020020

Ejemplares similares